These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29388189)

  • 1. Inequalities in zoster disease burden: a population-based cohort study to identify social determinants using linked data from the U.K. Clinical Practice Research Datalink.
    Jain A; van Hoek AJ; Walker JL; Forbes HJ; Langan SM; Root A; Smeeth L; Thomas SL
    Br J Dermatol; 2018 Jun; 178(6):1324-1330. PubMed ID: 29388189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink.
    Jain A; Walker JL; Mathur R; Forbes HJ; Langan SM; Smeeth L; van Hoek AJ; Thomas SL
    PLoS One; 2018; 13(11):e0207183. PubMed ID: 30439975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study.
    Amirthalingam G; Andrews N; Keel P; Mullett D; Correa A; de Lusignan S; Ramsay M
    Lancet Public Health; 2018 Feb; 3(2):e82-e90. PubMed ID: 29276017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012.
    Yanni EA; Ferreira G; Guennec M; El Hahi Y; El Ghachi A; Haguinet F; Espie E; Bianco V
    BMJ Open; 2018 Jun; 8(6):e020528. PubMed ID: 29880565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis.
    Grint DJ; McDonald HI; Walker JL; Amirthalingam G; Andrews N; Thomas S
    BMJ Open; 2020 Jan; 10(1):e034886. PubMed ID: 32001495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study.
    Andrews N; Stowe J; Kuyumdzhieva G; Sile B; Yonova I; de Lusignan S; Ramsay M; Amirthalingam G
    BMJ Open; 2020 Jul; 10(7):e037458. PubMed ID: 32641364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sociodemographic predictors of variation in coverage of the national shingles vaccination programme in England, 2014/15.
    Ward C; Byrne L; White JM; Amirthalingam G; Tiley K; Edelstein M
    Vaccine; 2017 Apr; 35(18):2372-2378. PubMed ID: 28363324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budget-Impact Analysis of Alternative Herpes Zoster Vaccine Strategies: A U.S. HMO Perspective.
    Graham J; Mauskopf J; Kawai K; Johnson KD; Xu R; Acosta CJ
    J Manag Care Spec Pharm; 2016 Jul; 22(7):872-88. PubMed ID: 27348287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster in Germany: quantifying the burden of disease.
    Ultsch B; Siedler A; Rieck T; Reinhold T; Krause G; Wichmann O
    BMC Infect Dis; 2011 Jun; 11():173. PubMed ID: 21679419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
    Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
    JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.
    Langan SM; Smeeth L; Margolis DJ; Thomas SL
    PLoS Med; 2013; 10(4):e1001420. PubMed ID: 23585738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis.
    Curran D; Hunjan M; El Ghachi A; El-Hahi Y; Bianco V; Ferreira G
    BMJ Open; 2019 Aug; 9(8):e023502. PubMed ID: 31462457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
    Matthews I; Lu X; Dawson H; Bricout H; O'Hanlon H; Yu E; Nozad B
    Vaccine; 2018 Nov; 36(46):7105-7111. PubMed ID: 30195489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of herpes zoster vaccination in an older United Kingdom population.
    Walker JL; Andrews NJ; Amirthalingam G; Forbes H; Langan SM; Thomas SL
    Vaccine; 2018 Apr; 36(17):2371-2377. PubMed ID: 29555217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RCGP Research and Surveillance Centre Annual Report 2014-2015: disparities in presentations to primary care.
    de Lusignan S; Correa A; Pathirannehelage S; Byford R; Yonova I; Elliot AJ; Lamagni T; Amirthalingam G; Pebody R; Smith G; Jones S; Rafi I
    Br J Gen Pract; 2017 Jan; 67(654):e29-e40. PubMed ID: 27993900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population.
    Tseng HF; Chi M; Smith N; Marcy SM; Sy LS; Jacobsen SJ
    J Infect Dis; 2012 Jul; 206(2):190-6. PubMed ID: 22669900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Hornberger J; Robertus K
    Ann Intern Med; 2006 Sep; 145(5):317-25. PubMed ID: 16954357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of herpes zoster disease in Norway.
    Mirinaviciute G; Quist-Paulsen E; Brantsæter AB; Flem E
    Vaccine; 2020 Apr; 38(18):3501-3507. PubMed ID: 31843267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.